Alison Heald

513 total citations
11 papers, 383 citations indexed

About

Alison Heald is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alison Heald has authored 11 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Infectious Diseases and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alison Heald's work include Pneumonia and Respiratory Infections (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and HIV/AIDS drug development and treatment (3 papers). Alison Heald is often cited by papers focused on Pneumonia and Respiratory Infections (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and HIV/AIDS drug development and treatment (3 papers). Alison Heald collaborates with scholars based in United States, Switzerland and Italy. Alison Heald's co-authors include Bernard Hirschel, R Auckenthaler, Hans Stalder, Laurent Kaiser, L Matter, Alfredo Morabia, S Rüttimann, Peter A. Benedict, W Wunderli and D Germann and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.

In The Last Decade

Alison Heald

11 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Heald United States 7 244 157 100 38 38 11 383
Luz Stella Muniz United States 8 499 2.0× 43 0.3× 121 1.2× 32 0.8× 22 0.6× 8 600
Carl Spindler Sweden 10 461 1.9× 60 0.4× 48 0.5× 7 0.2× 17 0.4× 15 524
Helen Hill United Kingdom 10 262 1.1× 112 0.7× 92 0.9× 2 0.1× 12 0.3× 16 441
Mary Bertin United States 7 309 1.3× 349 2.2× 45 0.5× 9 0.2× 3 0.1× 16 554
Antônio Carlos Moreira Lemos Brazil 13 177 0.7× 179 1.1× 165 1.6× 3 0.1× 6 0.2× 37 426
Kenneth W. Cross United Kingdom 5 210 0.9× 28 0.2× 61 0.6× 9 0.2× 40 1.1× 6 303
Leslie Forrester Canada 9 64 0.3× 121 0.8× 83 0.8× 7 0.2× 11 0.3× 15 267
Rick Player United States 6 273 1.1× 53 0.3× 51 0.5× 3 0.1× 19 0.5× 8 400
Hyeon Mi Yoo South Korea 10 249 1.0× 207 1.3× 39 0.4× 5 0.1× 32 0.8× 23 420
Tatiana V. Kulichenko Russia 9 157 0.6× 36 0.2× 37 0.4× 39 1.0× 12 0.3× 30 239

Countries citing papers authored by Alison Heald

Since Specialization
Citations

This map shows the geographic impact of Alison Heald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Heald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Heald more than expected).

Fields of papers citing papers by Alison Heald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Heald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Heald. The network helps show where Alison Heald may publish in the future.

Co-authorship network of co-authors of Alison Heald

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Heald. A scholar is included among the top collaborators of Alison Heald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Heald. Alison Heald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Beigel, John H., Jocelyn Voell, Paula Muñoz, et al.. (2017). Safety, tolerability, and pharmacokinetics of radavirsen (AVI‐7100), an antisense oligonucleotide targeting influenza a M1/M2 translation. British Journal of Clinical Pharmacology. 84(1). 25–34. 19 indexed citations
2.
Warren, Travis K., Chris A. Whitehouse, Jay Wells, et al.. (2016). Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques. PLoS neglected tropical diseases. 10(2). e0004456–e0004456. 23 indexed citations
3.
4.
Moss, Richard B., Alison Heald, Dana Mathews, et al.. (2005). 97 INS37217 (denufosol tetrasodium) inhalation solution: Phase 1 & 2 clinical experience. Journal of Cystic Fibrosis. 4. S27–S27. 1 indexed citations
5.
Moss, Richard B., Alison Heald, Dana Mathews, et al.. (2005). 98 Safety and Efficacy of INS37217 Inhalation Solution in Patient Subgroups: Results of a Phase 2 Multicentre Trial. Journal of Cystic Fibrosis. 4. S27–S27. 1 indexed citations
6.
Kaiser, Laurent, Daniel Lew, Bernard Hirschel, et al.. (1996). Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. The Lancet. 347(9014). 1507–1510. 135 indexed citations
7.
Trenholme, Gordon M., Laurent Kaiser, Bernard Hirschel, et al.. (1996). Effects of Antibiotic Treatment in the Subset of Common-Cold Patients Who Have Bacteria in Nasopharyngeal Secretions. Infectious Diseases in Clinical Practice. 5(7). 421–421. 5 indexed citations
8.
Opravil, Milos, M. Péchère, Adriano Lazzarin, et al.. (1995). Dapsone/Pyrimethamine May Prevent Mycobacterial Disease in Immunosuppressed Patients Infected with the Human Immunodeficiency Virus. Clinical Infectious Diseases. 20(2). 244–249. 16 indexed citations
9.
Heald, Alison, R Auckenthaler, F Borst, et al.. (1993). Adult bacterial nasopharyngitis. Journal of General Internal Medicine. 8(12). 667–673. 26 indexed citations
10.
Hirschel, Bernard, Adriano Lazzarin, Pierre Chopard, et al.. (1991). A Controlled Study of Inhaled Pentamidine for Primary Prevention ofPneumocystis cariniiPneumonia. New England Journal of Medicine. 324(16). 1079–1083. 132 indexed citations
11.
Heald, Alison, Markus Flepp, Jean‐Philippe Chave, et al.. (1991). Treatment for Cerebral Toxoplasmosis Protects against Pneumocystis carinii Pneumonia in Patients with AIDS. Annals of Internal Medicine. 115(10). 760–763. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luz Stella Muniz Breakdown of academic impact, for papers by Carl Spindler Breakdown of academic impact, for papers by Helen Hill Breakdown of academic impact, for papers by Mary Bertin Breakdown of academic impact, for papers by Antônio Carlos Moreira Lemos Breakdown of academic impact, for papers by Kenneth W. Cross Breakdown of academic impact, for papers by Leslie Forrester Breakdown of academic impact, for papers by Rick Player Breakdown of academic impact, for papers by Hyeon Mi Yoo Breakdown of academic impact, for papers by Tatiana V. Kulichenko
Rankless by CCL
2026